OneMedNet Corp (ONMD) · Peers
OneMedNet against the 14 other companies here in its SEC industry, Services-Commercial Physical & Biological Research. Each figure is the one on the company's own page; the median is the peers', and the rank is among all 15, highest first.
Measure by measure
| Measure | ONMD | Peer median | Rank |
|---|---|---|---|
| Market value | $278.05M | median $447.26M | 8 of 14 |
| P/S | 191.0× | median 4.3× | 1 of 13 |
| FCF yield | -2.5% | median 0.0% | 8 of 14 |
| Gross margin | -67.5% | median 52.4% | 6 of 7 |
| Operating margin | -695.7% | median -2.1% | 12 of 13 |
| Net margin | -584.2% | median -6.0% | 12 of 12 |
| Current ratio | 0.3× | median 1.5× | 12 of 15 |
| Stock pay / revenue | 173.1% | median 2.1% | 2 of 14 |
| Share count change | 58.7% | median 0.0% | 3 of 14 |
Green where OneMedNet is on the better side of the median, red where on the worse; no colour where higher is neither, like size or dividend yield.
The peers, largest first
| Company | Market value | P/E | ROIC | Score |
|---|---|---|---|---|
| ONMDOneMedNet Corp | $278.05M | P/E – | – | 3.5 |
| IQVIQVIA Holdings Inc | $44.55B | P/E 32.2× | 8.6% | 6.0 |
| INCYIncyte Corporation | $22.59B | P/E 15.8× | 73.6% | 8.8 |
| MEDPMedpace Holdings, Inc. | $17.31B | P/E 35.2× | – | 7.4 |
| CRLCharles River Laboratories | $14.38B | P/E – | 0.4% | 4.0 |
| ICLRIcon PLC | $13.03B | P/E 307.7× | 2.2% | 5.4 |
| OABIOmniAb, Inc. | $679.70M | P/E – | -18.3% | 4.1 |
| NRCNational Research Corp | $447.26M | P/E 81.9× | 12.0% | 4.6 |
| MXCTMaxcyte, Inc. | $133.65M | P/E – | -62.2% | 4.3 |
| BIAFbioAffinity Technologies, Inc. | $30.22M | P/E – | -505.1% | 3.5 |
| VSBCVitaspring Biomedical Co. Ltd. | $26.33M | P/E – | – | 2.9 |
| CBIHCannabis Bioscience International Holdings, Inc. | $2.33M | P/E – | – | 2.8 |
| ISPCiSpecimen Inc. | $2.31M | P/E – | – | 3.5 |
| FOXOFoxo Technologies Inc. | $182,393 | P/E – | -5.5% | 4.4 |
| ABSIAbsci Corp | – | P/E – | -220.9% | 3.3 |
The industry is the Standard Industrial Classification code the company registered with the SEC. It is a broad label: a peer group is a starting point for comparing, not proof that two businesses are alike. None of this is advice.